Inventor · disambiguated record
Guillaume Cottarel
Also filed as: COTTAREL GUILLAUME
17 granted patents·11 pending applications·429 citations·filing 1993–2024
96Inventor score
Top patents by PatentIndex Score
28 records- 0193US9399783B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2016·Granted Jul 26, 2016·14 cites·10 claims
- 0292US9745603B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2016·Granted Aug 29, 2017·9 cites·9 claims
- 0391US9267158B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2014·Granted Feb 23, 2016·13 cites·5 claims
- 0490US7241613B1Identification of Candida cell surface proteins and their usesOSCIENT PHARMACEUTICALS CORP·Filed 2003·Granted Jul 10, 2007·61 cites·2 claims
- 0589US10876137B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2017·Granted Dec 29, 2020·4 cites·10 claims
- 0689US5443962AMethods of identifying inhibitors of cdc25 phosphataseMITOTIX INC·Filed 1993·Granted Aug 22, 1995·70 cites·42 claims
- 0786US11821019B2Biological production of multi-carbon compounds from methaneINTREXON CORP·Filed 2020·Granted Nov 21, 2023·2 cites·19 claims
- 0882US6068982AUbiquitin conjugating enzymesMITOTIX INC·Filed 1996·Granted May 30, 2000·50 cites·34 claims
- 0981US9155792B2RecA inhibitors with antibiotic activity, compositions and methods of useCOTTAREL GUILLAUME·Filed 2007·Granted Oct 13, 2015·16 cites·13 claims
- 1080US6150137AImmunosuppressant target proteinsARIAD GENE THERAPEUTICS INC·Filed 1994·Granted Nov 21, 2000·31 cites·22 claims
- 1176US6509152B1Immunosuppressant target proteinsARIAD GENE THERAPEUTICS INC·Filed 1998·Granted Jan 21, 2003·34 cites·20 claims
- 1275US6127521AImmunosuppressant target proteinsARIAD GENE THERAPEUTICS INC·Filed 1998·Granted Oct 3, 2000·31 cites·16 claims
- 1373US6464974B1Immunosuppressant target proteinsARIAD PHARMACEUTICALS·Filed 1998·Granted Oct 15, 2002·27 cites·17 claims
- 1467US5968761AUbiquitin conjugating enzymesMITOTIX INC·Filed 1995·Granted Oct 19, 1999·28 cites·31 claims
- 1567US2005059803A1Immunosuppressant target proteinsARIAD GENE THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 1664US5744343AUbiquitin conjugating enzymesMITOTIX INC·Filed 1994·Granted Apr 28, 1998·23 cites·27 claims
- 1763US2011065898A1Immunosuppressant Target ProteinsARIAD GENE THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1861US2025108095A1Degradation of toxins in vivoAPERIAM BIO INC·Filed 2024·Application pending·0 cites
- 1960US2011015137A1Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activityUNIV BOSTON·Filed 2008·Application pending·0 cites
- 2057US2025108096A1Alcohol cleansing methodsAPERIAM BIO INC·Filed 2024·Application pending·0 cites
- 2154US2003054370A1Systematic discovery of new genes and genes discovered therebyFiled 2002·Application pending·0 cites
- 2252US2010028334A1Compositions and methods to potentiate colistin activityUNIV BOSTON·Filed 2007·Application pending·0 cites
- 2347US5801015ANucleic acid encoding a Candida cell cycle regulatory protein, TYP1 polypeptideMITOTIX INC·Filed 1995·Granted Sep 1, 1998·6 cites·20 claims
- 2447US2010234348A1Compositions and methods for potentiating antibiotic activityUNIV BOSTON·Filed 2007·Application pending·0 cites
- 2546US6251585B1Assay and reagents for identifying anti-proliferative agentsMITOTIX INC·Filed 1995·Granted Jun 26, 2001·10 cites·25 claims
- 2639US2002192827A1Novel vector for C. glabrata and the use thereofFiled 2002·Application pending·0 cites
- 2735US2012088271A1Use of an Endogenous 2-Micron Yeast Plasmid for Gene Over ExpressionHAERIZADEH FARZAD·Filed 2011·Application pending·0 cites
- 2830US2003104362A1Cell-cycle regulatory proteins from human pathogens, and uses related theretoFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Guillaume Cottarel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →